All Stories

  1. Monofunctional Platinum(II) Anticancer Agents
  2. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents
  3. Specific self-monitoring of metal-associated amyloid-β peptide disaggregation by a fluorescent chelator
  4. A copper–amyloid-β targeted fluorescent chelator as a potential theranostic agent for Alzheimer's disease
  5. Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy
  6. Glutathione boosting the cytotoxicity of a magnetic platinum(iv) nano-prodrug in tumor cells
  7. Sequence-specific detection of cytosine methylation in DNA via the FRET mechanism between upconversion nanoparticles and gold nanorods
  8. Functionalization of Platinum Complexes for Biomedical Applications
  9. A monofunctional trinuclear platinum complex with steric hindrance demonstrates strong cytotoxicity against tumor cells
  10. Platinum(II)-Gadolinium(III) Complexes as Potential Single-Molecular Theranostic Agents for Cancer Treatment
  11. A mitochondrion-targeting copper complex exhibits potent cytotoxicity against cisplatin-resistant tumor cells through multiple mechanisms of action
  12. Improving nuclease activity of copper(II)–terpyridine complex through solubilizing and charge effects of glycine
  13. Detecting and delivering platinum anticancer drugs using fluorescent maghemite nanoparticles
  14. Targeting and delivery of platinum-based anticancer drugs
  15. A platinum anticancer theranostic agent with magnetic targeting potential derived from maghemite nanoparticles
  16. Specific recognition of DNA depurination by a luminescent terbium(iii) complex
  17. Inhibitory action of macrocyclic platiniferous chelators on metal-induced Aβ aggregation
  18. Cytotoxic palladium(II) complexes of 8-aminoquinoline derivatives and the interaction with human serum albumin
  19. Noncovalent Interactions between a Trinuclear Monofunctional Platinum Complex and Human Serum Albumin
  20. New Trends and Future Developments of Platinum‐Based Antitumor Drugs
  21. Terbium(iii) complex as a luminescent sensor for human serum albumin in aqueous solution
  22. Monofunctional platinum complexes containing a 4-nitrobenzo-2-oxa-1,3-diazole fluorophore: Distribution in tumour cells
  23. Superparamagnetic magnetite nanocrystal clusters as potential magnetic carriers for the delivery of platinum anticancer drugs
  24. Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes
  25. Fast cleavage of a diselenide induced by a platinum(II)–methionine complex and its biological implications
  26. Reversible DNA Condensation Induced by a Tetranuclear Nickel(II) Complex
  27. Promotive Effect of the Platinum Moiety on the DNA Cleavage Activity of Copper-Based Artificial Nucleases
  28. Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin
  29. Effects of Cyclen and Cyclam on Zinc(II)- and Copper(II)-Induced Amyloid β-Peptide Aggregation and Neurotoxicity
  30. Fabrication of water soluble and biocompatible CdSe nanoparticles in apoferritin with the aid of EDTA
  31. Comparison of DNA binding and cleavage abilities between mono- and trinuclear copper(II) complexes of benzimidazole derivatives
  32. Recognition of phosphate anions in aqueous solution by a dinuclear zinc(II) complex of a cyclen-tethered terpyridine ligand
  33. Targeted binding of a platinum(II)–methionine complex to the disulfide linkage of a nonapeptide oxytocin
  34. Towards the rational design of platinum(ii) and gold(iii) complexes as antitumour agents
  35. Selective guanosine binding and cytotoxicity of a benzimidazole derived dinickel complex
  36. A Trinuclear Copper(II) Complex of 2,4,6-Tris(di-2-pyridylamine)-1,3,5-triazine Shows Prominent DNA Cleavage Activity
  37. A dinuclear monofunctional platinum(II) complex with an aromatic linker shows low reactivity towards glutathione but high DNA binding ability and antitumor activity
  38. Encapsulation of platinum anticancer drugs by apoferritin
  39. Selective sensing of dihydrogen phosphate anion by a fluorescent tetranuclear pentacoordinated zinc(ii) complex
  40. The Role of Sulfur in Platinum Anticancer Chemotherapy
  41. Antitumor active monofunctional platinum(II) complexes: Synthesis, structural characterization and reactivity towards biomolecules
  42. Disulfide Bond Cleavage Induced by a Platinum(II) Methionine Complex
  43. An Asymmetric Dizinc Phosphodiesterase Model with Phenolate and Carboxylate Bridges
  44. Crystal structure, DNA-binding ability and cytotoxic activity of platinum(II) 2,2′-dipyridylamine complexes
  45. Monofunctional Platinum Complexes Showing Potent Cytotoxicity against Human Liver Carcinoma Cell Line BEL-7402
  46. 5-Fluorouracil–cisplatin adducts with potential antitumor activity
  47. DNA-binding property and antitumor activity of bismuth(iii) complex with 1,4,7,10-tetrakis(2-pyridylmethyl)-1,4,7,10-tetraazacyclododecaneElectronic supplementary information (ESI) available: 1H-NMR, ES-MS and CD spectra. See http://www.rsc.org/suppdat...